"Hiberix" vaccine
Use of Hiberix vaccine
Administration of the vaccine in a dose of 0.5 ml intramuscularly:
- in younger children in the quadriceps femoris muscle,
- older children in the deltoid muscle.
It is allowed to administer the vaccine subcutaneously. Intravenous administration is categorically contraindicated.
Before vaccination, an examination of the child is indicated, to exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
-
What are the indications for the Hiberix vaccine?
The vaccine is intended for the prevention of purulent-septic diseases caused by the Haemophilus bacillus (Haemophilus influenzae type b strain). "Hiberix" does not prevent diseases caused by other types of Haemophilus influenzae.
-
What are the contraindications to the Hiberix vaccine?
Hypersensitivity to any component of the vaccine, if a neurological complication was detected after previous vaccination.
Vaccination is not given to children who have a history of convulsions, diseases accompanied by fever, as well as children who suffer from:
- uncontrolled epilepsy,
- progressive encephalopathy,
- and people receiving immunosuppressive therapy.
-
What are the side effects of the Hiberix vaccine?
After vaccination can be observed:
- loss of appetite
- irritability,
- drowsiness,
- diarrhea,
- temperature rise,
- redness,
- rash,
- pain and swelling at the injection site.
In the presence of mechanical inclusions or a strange color of the solution, the use of the vaccine is unacceptable.
priority
Must be from the Ministry of Health
Not available